Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?

LAWSON, K. (2008). Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies? Drug Discovery Today, 13 (7-8), 333-340.

Full text not available from this repository.
Link to published version:: https://doi.org/10.1016/j.drudis.2008.01.004
Related URLs:

    Abstract

    Fibromyalgia (FM) is a chronic pain condition, with auxiliary symptoms, such as sleep disturbances and fatigue. Although many of the mechanisms of action targeted by the drugs used to treat FM have been focused to the management of single symptoms, drugs (e.g. pregabalin, duloxetine) have now been identified that demonstrate a multidimensional effect. However, such drugs often fail to demonstrate acceptable efficacy in the majority of the patient population. Thus, the mechanisms of action of the drugs studied as treatments for FM are either identifying subgroups within the pathophysiology of the condition or suggesting that a mechanism of action that will offer universal efficacy has, as yet, to be identified.

    Item Type: Article
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomolecular Sciences Research Centre
    Identification Number: https://doi.org/10.1016/j.drudis.2008.01.004
    Page Range: 333-340
    Depositing User: Users 4 not found.
    Date Deposited: 25 Feb 2011 16:38
    Last Modified: 13 Jun 2017 12:48
    URI: http://shura.shu.ac.uk/id/eprint/3228

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics